Torrent Pharmaceuticals Limited has initiated a postal ballot process to seek shareholder assent for the appointment of Shanti Ekambaram as an Independent Director. The Board of Directors proposes her appointment for a term of three consecutive years, effective from July 30, 2026, subject to member approval via a special resolution. This move aims to leverage Ms. Ekambaram’s extensive financial services and governance expertise to strengthen the company’s strategic leadership and compliance frameworks.

The postal ballot is being conducted in compliance with Section 110 of the Companies Act, 2013, Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with Ministry of Corporate Affairs (MCA) circulars, the notice has been dispatched electronically to members whose email IDs are registered as of the cut-off date, July 31, 2026. Central Depository Services (India) Limited (CDSL) has been engaged to facilitate the e-voting process.

Ms. Ekambaram, aged 63, brings 39 years of experience in financial services, including a 35-year tenure at Kotak Mahindra Bank where she served as Deputy Managing Director and Whole-time Director until 2025. She previously led Kotak Mahindra Capital Company, playing a pivotal role in pioneering India’s first book-building IPO transaction. Her professional background includes strategic oversight across digital banking, treasury, human resources, and internal audit. She holds directorships at Havells India Limited, Kotak Securities Limited, and Kotak Mahindra Capital Company Limited.

Key Voting Details

Members holding shares in physical or demat form as of the cut-off date are eligible to vote. The e-voting facility is accessible via the CDSL platform for individual demat holders through their depository login credentials. Non-individual members and those holding physical shares must register on the CDSL e-voting portal using their folio or beneficiary details. Physical copies of the ballot are not being distributed; all voting must be conducted electronically.

Board Composition and Remuneration

Upon confirmation by shareholders, Ms. Ekambaram will serve as a member of the Audit Committee, Securities Transfer and Stakeholders Relationship Committee, and the Nomination and Remuneration Committee. As per the explanatory statement, she is not liable to retire by rotation under Section 149(13) read with the explanation to Section 152(6) of the Companies Act, 2013.

Ms. Ekambaram does not hold any shares in Torrent Pharmaceuticals Limited and has no relationship with other directors or key managerial personnel. Since her interim appointment as an Additional Director on July 30, 2026, she has attended one board meeting and received remuneration of ₹ 1 lakh in the form of sitting fees. Her future remuneration will be determined in accordance with Resolution No. 9 of the 51st Annual General Meeting Notice dated May 24, 2024, or subsequent resolutions passed by members. Rajesh Parekh & Co. has been appointed as the scrutinizer to ensure the fairness and transparency of the voting process.

A notable block trade in torrent pharmaceuticals was recorded on the National Stock Exchange (NSE), drawing attention from market participants. The transaction involved approximately 59,070 shares, executed at a price of ₹4961.50 per share, aggregating to a total deal value of ₹29.31 crores.

Block Trade Details

The following table summarizes the key parameters of the block trade:

Market Significance

Block trades are large, privately negotiated transactions that are executed on the exchange platform and are typically associated with institutional investors such as mutual funds, foreign portfolio investors, or other large entities. Such trades are closely monitored by market participants as they can reflect significant shifts in institutional positioning within a stock. The block trade in Torrent Pharmaceuticals at ₹4961.50 per share, covering approximately 59,070 shares, represents a transaction of considerable size on the NSE.